GGrantIndex
← Leaderboards

Lisa D Yee

Ohio State University

$3,382,725
Attributed
$6,281,527
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$6,281,527 · 6

By mechanism

U01$3,967,166 · 1
R01$1,293,581 · 1
K07$663,250 · 1
R21$349,791 · 1
M01$7,739 · 2

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Biological Markers

Research focus

Biological MarkersMammary Gland ParenchymaGene ExpressionBaseHigh Risk WomanTissuesTransgenic MiceOutcome ForecastOverexpressionMalignant NeoplasmsTriple-Negative Invasive Breast CarcinomaSignal TransductionCellsTumorLinkHigh RiskMalignant Breast NeoplasmIncidenceProspectiveMammary GlandWomanFatty AcidsPublic Health RelevanceMolecular

Grant awards (25)

Combined breast MRI/biomarker strategies to identify aggressive biology$649,862
U01 · FY2020 · CA
Combined breast MRI/biomarker strategies to identify aggressive biology$656,559
U01 · FY2019 · CA
Combined breast MRI/biomarker strategies to identify aggressive biology$178,623
U01 · FY2019 · CA
Combined breast MRI/biomarker strategies to identify aggressive biology$663,841
U01 · FY2018 · CA
Combined breast MRI/biomarker strategies to identify aggressive biology$190,203
U01 · FY2018 · CA
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$146,146
R01 · FY2018 · CA · contact PI
Combined breast MRI/biomarker strategies to identify aggressive biology$695,009
U01 · FY2017 · CA
Diversity Supplement to Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology$190,203
U01 · FY2017 · CA
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$96,783
R01 · FY2017 · CA · contact PI
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$92,521
R01 · FY2017 · CA · contact PI
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$319,550
R01 · FY2016 · CA · contact PI
Combined breast MRI/biomarker strategies to identify aggressive biology$698,567
U01 · FY2015 · CA
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$319,550
R01 · FY2015 · CA · contact PI
Combined breast MRI/biomarker strategies to identify aggressive biology$44,299
U01 · FY2015 · CA
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention$319,031
R01 · FY2014 · CA · contact PI
OMEGA 3 FATTY ACIDS SUPPLEMENTS IN WOMEN AT HIGH RISK FOR BREAST CANCER$5,890
M01 · FY2008 · RR · contact PI
OMEGA 3 FATTY ACIDS SUPPLEMENTS IN WOMEN AT HIGH RISK FOR BREAST CANCER$1,849
M01 · FY2007 · RR · contact PI
HER2/neu and dietary fat: interactions in breast cancer$156,936
R21 · FY2006 · CA · contact PI
HER2/neu and dietary fat: interactions in breast cancer$192,855
R21 · FY2005 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$66,325
K07 · FY2005 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$132,650
K07 · FY2004 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$132,650
K07 · FY2003 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$66,325
K07 · FY2002 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$132,650
K07 · FY2001 · CA
FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTION$132,650
K07 · FY2000 · CA